| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.37 | 0.02 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |